ChemDiv is the partner of choice for medicinal chemistry research based on its extensive lead optimization capability underscored by its broad preclinical expertise in discovery biology, synthetic chemistry, rational drug design and informatics.
LEAD OPTIMIZATION
The discovery and development process includes: assessment of project tractability; IP landscaping, computer aided drug design; structure-activity relationship studies; early DMPK and in vivo efficacy assessment.
TRACK RECORD
ChemDiv's developed both selective and dual kinase inhibitors, vasculature-targeting agents, “non-toxic” anti-mitotics, dual and specific pGPCR antagonists, ion channel and developmental pathway modulators for leading biotechnology and pharmaceutical companies.
Please contact ChemDiv to discuss your synthetic chemistry needs!
Register here for the secure Customer Area to obtain access to advanced ChemDiv services, databases and a personalized space.
|
